Steatotic liver disease has historically received less attention in metabolic risk evaluation. While HbA1c and cardiovascular risk factors are regularly assessed, more comprehensive evaluation of liver disease has not consistently been incorporated into clinical practice. As a result, many patients may remain undiagnosed until later stages of disease.
Healthful Living Rx 3
Made with FlippingBook flipbook maker